Zobrazeno 1 - 10
of 272
pro vyhledávání: '"David W.M. Muller"'
Publikováno v:
JACC: Case Reports, Vol 2, Iss 6, Pp 866-869 (2020)
A 71-year-old man with chronic atrial fibrillation underwent insertion of a left atrial appendage occlusion device. Before release, a large thrombus was noted within the left atrium, attached to the left atrial appendage occluder delivery system. Wit
Externí odkaz:
https://doaj.org/article/1914a5d82ba14f5282c3eb94626932cf
Autor:
Sara Hungerford, Nicole Bart, Paul Jansz, Sharon Kay, Sam Emmanuel, Mayooran Namasivayam, Gry Dahle, Alison Duncan, Christopher Hayward, David W.M. Muller
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 32, Iss , Pp 100687- (2021)
Background: Transapical transcatheter mitral valve implantation (TMVI) may be a therapeutic option for patients with severe mitral regurgitation (MR) excluded from cardiac surgery due to excessive risk. Exclusion criteria frequently include pulmonary
Externí odkaz:
https://doaj.org/article/8880160d746245408424fb6733addc97
Autor:
Ingrid Tarr, Stephanie Hesselson, Siiri E. Iismaa, Emma Rath, Steven Monger, Michael Troup, Ketan Mishra, Claire M.Y. Wong, Pei-Chen Hsu, Keerat Junday, David T. Humphreys, David Adlam, Tom R. Webb, Anna A. Baranowska-Clarke, Stephen E. Hamby, Keren J. Carss, Nilesh J. Samani, Monique Bax, Lucy McGrath-Cadell, Jason C. Kovacic, Sally L. Dunwoodie, Diane Fatkin, David W.M. Muller, Robert M. Graham, Eleni Giannoulatou
Publikováno v:
Circulation. Genomic and precision medicine. 15(4)
Background: Spontaneous coronary artery dissection (SCAD) is a cause of acute coronary syndrome that predominantly affects women. Its pathophysiology remains unclear but connective tissue disorders (CTD) and other vasculopathies have been observed in
Autor:
Mayooran Namasivayam, Thomas Meredith, David W.M. Muller, David Alexander Roy, Andrew K. Roy, Jason Ciril Kovacic, Christopher S. Hayward, Michael P. Feneley
Publikováno v:
Frontiers in Cardiovascular Medicine. 10
BackgroundModerate severity aortic stenosis (AS) is poorly understood, is associated with subclinical myocardial dysfunction, and can lead to adverse outcome rates that are comparable to severe AS. Factors associated with progressive myocardial dysfu
Publikováno v:
JACC: Case Reports. 4:491-496
Autor:
Sara L. Hungerford, Nicole K. Bart, Ning Song, Paul Jansz, Gry Dahle, Alison Duncan, Christopher Hayward, David W.M. Muller
Publikováno v:
JACC: Cardiovascular Imaging. 15:1514-1516
Autor:
Paul Sorajja, Gry Dahle, Jonathon Leipsic, Vasilis C. Babaliaros, Michael L Chuang, Paul Jansz, Philipp Blanke, Thomas Modine, Paul A. Grayburn, Francesco Bedogni, Mayra Guerrero, Vinod H. Thourani, Paolo Denti, Alison Duncan, Vinay Badhwar, Nicolas Dumonteil, David W.M. Muller, Brian Bethea
Publikováno v:
Journal of the American College of Cardiology. 78:1847-1859
Background Transcatheter mitral valve replacement (TMVR) is feasible for selected patients with severe mitral regurgitation (MR) who are poor candidates for valve surgery. Intermediate-term to long-term TMVR outcomes have not been reported. Objective
Publikováno v:
European journal of heart failureReferences.
Over the past decade, transcatheter mitral valve replacement (TMVR) technologies have evolved with the objective of improving outcomes for patients with severe mitral regurgitation (MR) deemed unsuitable for conventional mitral valve surgery. Althoug
Autor:
Natasha Gorrie, Audrey Adji, S. Hungerford, Linda Lin, Christopher S. Hayward, Andrew Jabbour, Michael F. O'Rourke, David W.M. Muller, Nicole K. Bart
Publikováno v:
International Journal of Clinical and Experimental Physiology. 8:88-94
Background and Aim: The left ventricle (LV) faces a dual afterload in patients with aortic stenosis (AS) – both from the valve and vasculature. Together they form the global LV load. Two cardiac magnetic resonance (CMR) techniques have been describ
Autor:
Sanjay Sookhu, Pedram Kazemain, Meet Shah, Alexander Ochman, David W.M. Muller, Joellen Schmidt, Raffaele Corbisiero
Publikováno v:
Pacing and Clinical Electrophysiology. 44:967-972
Background Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with drug refractory heart failure OBJECTIVES: This study sought to compare the longest RVsense to LVsense activation time (sLAT) versus the longest RVpac